ReShape Weightloss Inc (RSLS)

OTC Markets
6.4000
0.0000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.0000/0.0000
  • Day's Range:
    5.1100 - 6.4750

RSLS Overview

Prev. Close
5.5
Day's Range
5.11-6.475
Revenue
11.73M
Open
5.3
52 wk Range
4.55-6.475
EPS
-3.19
Volume
0
Market Cap
10.78M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
271,248
P/E Ratio
-
Beta
1.69
1-Year Change
0%
Shares Outstanding
18,693,219
Next Earnings Date
-
What is your sentiment on ReShape Weightloss Inc?
or
Market is currently closed. Voting is open during market hours.

ReShape Weightloss Inc News

ReShape Weightloss Inc Analysis

ReShape Weightloss Inc Company Profile

ReShape Weightloss Inc Company Profile

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuySell
SummaryStrong BuyStrong BuyStrong BuyStrong BuySell
  • 2 dollars tomorrow
    0
    • sure?
      0
    • buffone
      0
  • 2 dollars tomorrow
    1
    • This stock won't go up even with good news.. Seems to be a lame duck.
      0
      • i disagree. if this company can provide a true type 2 diabetes treatment, it will be the number 1 used treatment. at .86 im buying and holding until $2. at a minimum, buy and wait until the investers on wednesday.
        0
      • Good luck, it will be nice if that happens. Hope you make money,
        0
    • Up n down
      2
      • I guess an opportunity.
        0
        • .10 coming all the way from $20 ha
          0
          • What is your opinion about this stock ? Why soared today? And what good news we know so far?
            0
            • I bought 50 shares yesterday :( Hopefully they rebound quick
              0
          • Hopefully better news December 12th
            0
            • R/S on Wednesday? Meeting @ 11 am BULLISH
              0
              • Buy now...
                0
                • Any news?
                  0
                • News Wednesday Nov 30th at 11 am and more news Dec 12th
                  0